Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

910323

	registered interest
	date	23/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the reasons for the NHS not meeting the operational standard on the 62 day time limit between urgent GP referral and first definitive treatment for cancer; and if he will make a statement.
	tabling member constituency	Westmorland and Lonsdale
	tabling member printed	Tim Farron
	uin	147422
	answer	answer is ministerial correction date of answer 04/06/2018 answer text <p>There has been a continuing rise in demand for cancer services, with urgent general practitioner referrals for cancer rising by over 70,000 compared to last year.</p><p> </p><p>Achieving the 62-day standard was a key objective in the Government’s mandate to NHS England for 2017-18 and this has been rolled forward into 2018-19. NHS England is investing this year in initiatives to recover and maintain the 62-day standard nationally, such as pathway coordinators and timed, standardised pathways.</p><p> </p><p>The National Health Service is committed to achieving the 62-day cancer waiting times standard in 2018/19, and to maintaining performance against the other cancer waiting times standards.</p><p> </p><p>Latest data for March 2018 shows that the National Health Service is meeting six out of eight cancer waiting times standards.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 04/06/2018 13:51:48 answering member 4067 label Biography information for Steve Brine
	tabling member	1591 label Biography information for Tim Farron

910325

	registered interest
	date	23/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 November 2017 to Question 114778, when the postcode-level dataset which will enable the calculation of travel times to radiotherapy centres will be published.
	tabling member constituency	Westmorland and Lonsdale
	tabling member printed	Tim Farron
	uin	147424
	answer	answer is ministerial correction date of answer 04/06/2018 answer text <p>The National Cancer Registration and Analysis Service intend to publish reports on travel times for cancer patients in June 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 04/06/2018 13:54:19 answering member 4067 label Biography information for Steve Brine
	tabling member	1591 label Biography information for Tim Farron

910345

	registered interest
	date	23/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy Integration Fund
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what funds have been appropriated from the Pharmacy Integration Fund, in each year on (a) schemes to support pharmacists working in GP surgeries, (b) schemes to support community pharmacies to become better integrated with the NHS and (c) deferring the cost of (i) other parts of the NHS and (ii) wider Government expenditure.
	tabling member constituency	Burnley
	tabling member printed	Julie Cooper
	uin	147482
	answer	answer is ministerial correction date of answer 08/06/2018 answer text <p>The Pharmacy Integration Fund (PhIF) programme of work started in 2016/17. From the PHIF, funding for schemes to support pharmacists working in general practitioner surgeries was £0 in 2016/17 with £5 million allocated in both 2017/18 and 2018/19. In 2016/17, £210,000 was allocated to schemes to support community pharmacies to become better integrated with the National Health Service, with a further estimated spend of £2,140,000 in 2017/18 and £2.5 million allocated for 2018/19. These figures do not however include funding for a wide range of Health Education England training schemes, including for community pharmacy staff which is additional.</p><p> </p><p>In 2016/17, £1,784,000 and an estimated £21,799,630 in 2017/18 was appropriated from the PhIF to support other parts of the NHS.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/06/2018 10:46:10 answering member 4067 label Biography information for Steve Brine
	tabling member	4405 label Biography information for Julie Cooper

910349

	registered interest
	date	23/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy Integration Fund
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Parliamentary Under-Secretary of State for Health of 20 December 2016, Official Report, how much of the £300 million pharmacy integration fund has been expended.
	tabling member constituency	Burnley
	tabling member printed	Julie Cooper
	uin	147484
	answer	answer is ministerial correction date of answer 08/06/2018 answer text <p>Spend on the Pharmacy Integration Fund was £216,305 in 2016/17 and is estimated to be £18,200,370 in 2017/18. A further £40 million has been committed for 2018/19.</p><p> </p><p>Delays to planned expenditure did result in an underspend against the funding allocated to this programme. As is standard Government finance procedure, underspends cannot be carried forward by either NHS England or the Department. As a result some of this funding was appropriated to support other programmes outside of pharmacy. The Government however remains committed to this programme which is already having a real impact and which will continue to develop.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/06/2018 11:02:28 answering member 4067 label Biography information for Steve Brine
	tabling member	4405 label Biography information for Julie Cooper

910350

	registered interest
	date	23/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy Integration Fund
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Parliamentary Under-Secretary of State for Health of 20 December 2016, Official Report, what projects have been funded through the pharmacy integration fund to support improvements in (a) repeat prescriptions and (b) minor ailment services in England.
	tabling member constituency	Burnley
	tabling member printed	Julie Cooper
	uin	147485
	answer	answer is ministerial correction date of answer 07/06/2018 answer text <p>The Pharmacy Integration Fund (PhIF) has been used to support the employment of pharmacists in integrated urgent care, general practice and care homes where their expert knowledge is helping to optimise the use of medicines and improve clinical effectiveness to deliver better outcomes for patients, including in respect to repeat prescriptions. They receive additional training enabling them to prescribe and have access to the full clinical record meaning they are well placed to support patients with complex polypharmacy and multiple co-morbidities. Alongside this, the NHS Urgent Medicines Supply Advanced Service has made it easier and faster for patients to access medication that they have previously been prescribed.</p><p> </p><p>To further support and promote the use of pharmacies by patients with minor ailments, the Digital Minor Illness Referral Service is piloting new urgent care pathways to direct patients into community pharmacy from NHS 111 Online and the NHS 111 phone line. In parallel, Government continues to promote pharmacy as the first port of call for a wide range of minor health concerns through the “Stay Well Pharmacy” campaign.</p><p> </p><p>Underpinning these work streams the PhIF is also funding training and leadership programmes which are also expected to drive improvements across these areas.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/06/2018 16:11:02 answering member 4067 label Biography information for Steve Brine
	tabling member	4405 label Biography information for Julie Cooper